Biotech’s Bold Leap. A Future Beyond Compliance Struggles?
Digital Innovation: The Future of Biotech Compliance? In a rapidly evolving biotech landscape, CERO Therapeutics’ recent compliance challenges with NASDAQ might just be the catalyst sparking a transformative shift towards digital solutions. As CERO navigates financial turbulence, its journey underscores a larger
